bioMérieux Share Price Euronext Paris
Equities
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.19B 335B | Sales 2025 * | 4.19B 4.5B 361B | Capitalization | 11.71B 12.58B 1,007B |
---|---|---|---|---|---|
Net income 2024 * | 467M 502M 40.16B | Net income 2025 * | 527M 566M 45.32B | EV / Sales 2024 * | 2.93 x |
Net cash position 2024 * | 263M 283M 22.65B | Net cash position 2025 * | 444M 477M 38.14B | EV / Sales 2025 * | 2.69 x |
P/E ratio 2024 * |
25.9
x | P/E ratio 2025 * |
22.9
x | Employees | - |
Yield 2024 * |
0.87% | Yield 2025 * |
1% | Free-Float | 36.21% |
Latest transcript on bioMérieux
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 31/10/16 |
Chairman | 50 | 15/04/04 | |
Director of Finance/CFO | 47 | 28/02/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14/09/06 | |
Director/Board Member | 63 | 31/12/04 | |
Chairman | 50 | 15/04/04 |
1st Jan change | Capi. | |
---|---|---|
+0.13% | 8.37B | |
-1.12% | 5.4B | |
+20.35% | 5.27B | |
-0.74% | 4.63B | |
-54.59% | 3.13B | |
+24.56% | 2.77B | |
-8.47% | 2.25B | |
-1.86% | 1.95B | |
+24.03% | 1.79B |